Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophages.
Enterococci are commensal organisms in the alimentary tract. However, they can cause a variety of life-threatening infections, especially in nosocomial settings. We hypothesized that induction of cell death might enable these facultative pathogenic bacteria to evade the innate immune response and to cause infections of their host. We demonstrate that E. faecium when exposed to lysozyme induces cell death in macrophages in vitro and in vivo. Flow cytometric analyses of J774A.1 macrophages infected with E. faecium revealed loss of cell membrane integrity indicated by uptake of propidium iodide and decrease of the inner mitochondrial transmembrane potential DeltaPsi(m). Inhibition of caspases, treatment of macrophages with cytochalasin D, or rifampicin did not prevent cells from dying, suggesting cell death mechanisms that are independent of caspase activation, bacterial uptake, and intracellular bacterial replication. Characteristics of necrotic cell death were demonstrated by both lack of procaspase 3 activation and cell shrinkage, electron microscopy, and release of lactate dehydrogenase. Pretreatment of E. faecium with lysozyme and subsequently with broad spectrum protease considerably reduced cell death, suggesting that a bacterial surface protein is causative for cell death induction. Moreover, in a mouse peritonitis model we demonstrated that E. faecium induces cell death of peritoneal macrophages in vivo. Altogether, our results show that enterococci, under specific conditions such as exposure to lysozyme, induce necrotic cell death in macrophages, which might contribute to disseminated infections by these facultative pathogenic bacteria.
Gröbner
Sabine
S
Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Elfriede-Aulhorn-Str. 6, 72076 Tübingen, Germany. sabine.groebner@med.uni-tuebingen.de
Fritz
Evelyn
E
Schoch
Friederike
F
Schaller
Martin
M
Berger
Alexander C
AC
Bitzer
Michael
M
Autenrieth
Ingo B
IB
D000818:Animals; D017209:Apoptosis; D001426:Bacterial Proteins / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D016923:Cell Death / Q000502:physiology; D003428:Cross Infection / Q000378:metabolism / Q000473:pathology; D016984:Enterococcus faecium / Q000378:metabolism; D005260:Female; D008264:Macrophages / Q000378:metabolism / Q000382:microbiology* / Q000473:pathology*; D017737:Macrophages, Peritoneal / Q000378:metabolism; D008564:Membrane Potentials; D051379:Mice; D008810:Mice, Inbred C57BL; D008928:Mitochondria / Q000378:metabolism; D009113:Muramidase / Q000378:metabolism; D009336:Necrosis / Q000378:metabolism / Q000473:pathology
D001426:Bacterial Proteins; D009113:Muramidase; D053148:Caspase 3; D020169:Caspases
Infect Immun. 2009 Jan;77(1):485-91
19001080
BMC Bioinformatics. 2007 Nov 01;8 Suppl 7:S2
18047719
J Exp Med. 1974 May 1;139(5):1228-48
4825244
J Cell Biol. 2001 Nov 12;155(4):637-48
11696559
Clin Microbiol Rev. 1990 Jan;3(1):46-65
2404568
PLoS Pathog. 2007 Jul 27;3(7):e102
17676995
Cell Microbiol. 2005 Aug;7(8):1087-97
16008576
FASEB J. 2004 Aug;18(11):1185-91
15284218
Clin Microbiol Infect. 2006 Dec;12(12):1193-8
17121625
Exp Cell Res. 1999 Apr 10;248(1):280-93
10094834
J Biol Chem. 1997 Dec 19;272(51):32436-42
9405453
Mediators Inflamm. 2004 Dec;13(5-6):349-55
15770051
Clin Cancer Res. 2008 Jun 1;14(11):3520-8
18519785
Biull Eksp Biol Med. 1964 Dec;58:39-41
14317414
J Immunol. 2008 Apr 1;180(7):4865-74
18354210
J Bacteriol. 2006 Feb;188(3):902-8
16428393
Comp Biochem Physiol A Mol Integr Physiol. 2001 Oct;130(3):401-9
11913453
Vaccine. 2004 Feb 17;22(7):822-30
15040934
J Antimicrob Chemother. 2004 Feb;53(2):167-73
14729736
J Clin Invest. 2005 Nov;115(11):3117-27
16276417
Cell. 1998 May 1;93(3):373-83
9590172
J Endod. 2004 Apr;30(4):209-12
15085047
Infect Immun. 2007 Nov;75(11):5390-8
17785473
J Exp Med. 1984 Jul 1;160(1):55-74
6330272
J Biol Chem. 2009 Jan 9;284(2):862-71
19001420
Mol Cell Biochem. 1984 Sep;63(2):165-89
6387440
Curr Pharm Des. 2002;8(9):671-93
11945164
Clin Infect Dis. 2005 Aug 1;41(3):327-33
16007529
J Exp Med. 1991 Nov 1;174(5):1049-58
1940787
Cell Death Differ. 2003 Nov;10(11):1260-72
12894214
Clin Microbiol Rev. 1994 Oct;7(4):462-78
7834601
Clin Microbiol Rev. 1993 Oct;6(4):428-42
8269394
Eur J Immunol. 2004 May;34(5):1461-71
15114680
Innate Immun. 2009 Feb;15(1):3-12
19201820
J Hosp Infect. 2007 Sep;67(1):49-55
17669548
Crit Care Resusc. 2007 Mar;9(1):69-75
17352670
J Immunol. 2008 Mar 15;180(6):4133-8
18322224
J Clin Microbiol. 1986 Dec;24(6):963-7
3782460
Microbiol Immunol. 1993;37(4):265-70
8350769